Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA red rash around your Mounjaro injection site is one of the more common local reactions people notice when starting tirzepatide, particularly in the first few weeks of treatment. Most of the time it signals a minor skin response, not a reason to stop — but some presentations do need prompt attention. Here's a practical, step-by-step guide to reading what your skin is telling you, so you can act correctly rather than panic or ignore it. As a prescription-only medicine, tirzepatide is prescribed after clinical assessment, and any skin change that concerns you is worth discussing with your prescriber before making changes to your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
As soon as you notice a skin change, take a proper look in good light rather than glancing and moving on. Note the size of the affected area. A reaction confined to roughly a coin-sized patch around the injection point (some redness, mild swelling, warmth or a small raised wheal) is the classic local injection-site response documented in the NHS tirzepatide medicines page. This kind of reaction often appears within an hour and fades over one to three days. If you are unsure whether what you are seeing is typical, our guide to red marks around the Mounjaro injection site explains the difference between normal post-injection redness and patterns worth monitoring more closely. If the redness is spreading in a ring outward from the site, growing larger over hours rather than smaller, or if you can see distinct blistering, photograph it. That photo gives your prescriber something concrete to work with if you contact them. This simple one-minute check, done consistently after each injection, builds an accurate picture of how your skin is responding over time.
Also note whether you feel unwell in any way beyond the local site. Rash plus dizziness, tight chest or difficulty swallowing shifts the situation entirely, see Step 3.
The majority of localised injection-site rashes trace back to a handful of correctable factors. Injecting repeatedly into the same patch of skin is at the top of that list. Subcutaneous tissue needs time to recover, and failing to rotate means cumulative trauma to the same spot. The three licensed sites for Mounjaro are the abdomen (avoiding a 5 cm radius around the navel), the front or outer thigh, and the upper arm. Move around within each site and switch between sites from one week to the next, a scheme our prescribers recommend to patients regularly on the Mounjaro injection technique page.
Technique matters too. Injecting cold medication straight from the fridge increases local discomfort and can trigger a more pronounced inflammatory response. Let the pen sit at room temperature for around 30 minutes before use, the exact storage window is set out in the leaflet; always check it there rather than assuming. Cleaning the skin first with an alcohol swab and letting it dry fully before inserting the needle also reduces the chance of a reaction; medical-grade alcohol swabs designed for injectable medicines are available if you don't already use them. Finally, pinching the skin gently before inserting rather than pressing hard into flat tissue can reduce mechanical irritation.
If you have sensitive skin generally or a history of eczema, the adhesive from pen tip covers occasionally triggers a contact reaction rather than the medicine itself, worth checking whether the redness is shaped exactly like the cap contact area. For a closer look at the different rash patterns that can develop, including how contact reactions compare to other responses, our page on Mounjaro rash at the injection site covers the common presentations in detail.
A small subset of skin reactions are not local irritation but early signals of something that needs medical assessment the same day. Get help promptly if any of the following apply: the rash is spreading rapidly beyond the injection site; there is swelling of the lips, tongue or throat; you develop hives across the body; breathing feels restricted; or you feel lightheaded alongside the skin change. These patterns can indicate a systemic allergic or hypersensitivity reaction. The NHS medicines information for tirzepatide lists serious allergic reactions as a rare but recognised risk, and the guidance is clear: stop the injection and seek urgent help.
Separately, a rash that is painful rather than itchy, warm to the touch, and worsening over 24 to 48 hours could suggest a localised skin infection at the injection site. This is uncommon when technique is correct, but it does occur and requires assessment by a clinician rather than watchful waiting. Do not apply over-the-counter antibiotic cream and hope for the best if the site looks infected.
There is also a broader pattern called lipohypertrophy, where repeated injections in one area cause the fatty tissue to thicken and harden. This is not usually a rash as such, but the skin over the area can look and feel different, and medication absorbed through hardened tissue becomes less predictable. If you notice a firm lump developing under older injection spots, raise it at your next clinical review. You can find more detail on injection-site changes, including what discolouration typically looks like, on our page on injection-site redness.
Between the two ends of the spectrum (mild and self-resolving versus urgent) sits a middle category: reactions that are not dangerous but are not settling either. If a localised rash persists beyond five to seven days, is getting larger rather than smaller, or is appearing consistently in the same pattern after every injection despite rotating sites, contact your prescriber before your next dose. They may want to review your injection technique, consider whether a different injection site would help, or assess whether the reaction pattern warrants any change to your treatment plan.
Persistent or unusual injection-site reactions are one of the reasons every repeat supply at nume involves a clinical review, not an automatic refill. A prescriber who knows your history can distinguish a technique issue from a true drug reaction far more accurately than any checklist can. If you have questions about your current reaction and you're already a patient, our support team can connect you with a prescriber the same day. Those exploring whether Mounjaro is right for them can find treatment options and eligibility information on our free consultation page.
For context on cost if you're weighing up whether to continue privately, our Mounjaro injection offers page sets out current pricing and what is included, alongside a straightforward breakdown of what UK providers include in their pricing on the Mounjaro price comparison page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.